Stockscreener 앱 받기
28.67
3.40%
-1.01
시간 외 거래:
28.53
-0.14
-0.49%
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers: It's Time To Get Aggressive (NYSE:HIMS) - Seeking Alpha
Surging Q3 Revenue And Cash Pile Could Be A Game Changer For Hims & Hers Health (HIMS) - Yahoo Finance
Cold Spring Harbor Laboratory Appoints Jack Abraham and Terri Keogh to Board of Trustees - Yahoo Finance Singapore
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
HIMS Stock Sees Bearish Sentiment Amidst Increased Volatility - GuruFocus
Looking At Hims & Hers Health's Recent Unusual Options Activity - Benzinga
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? - Yahoo Finance
Noteworthy Monday Option Activity: SKYT, CLOV, HIMS - Nasdaq
Kelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch - GlobeNewswire Inc.
Hims & Hers Stock Approaches a Pivotal Juncture - AD HOC NEWS
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care - Nasdaq
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
Assessing Hims & Hers Health (HIMS) Valuation After Recent Share Price Volatility - Yahoo Finance
Telehealth Stock Popular With Bulls Despite Underperformance - Schaeffer's Investment Research
Hims & Hers Health: The Reset Nobody Expected (NYSE:HIMS) - Seeking Alpha
Y Intercept Hong Kong Ltd Grows Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
A Profitable Company Under Siege: The Curious Case of Hims & Hers - AD HOC NEWS
End Of Novo Nordisk GLP-1 Deal Could Be A Game Changer For Hims & Hers Health (HIMS) - Sahm
Peering Into Hims & Hers Health Inc's Recent Short Interest - Sahm
Lobbying Update: $330,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Healthcare Stocks To Keep An Eye OnJanuary 23rd - MarketBeat
Steadview Capital Management LLC Purchases 311,845 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
TipRanksXAI Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $31 - Futubull
183,304 Shares in Hims & Hers Health, Inc. $HIMS Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Hims Hair Loss Solutions: Will the Convenient Option Work for You? - The National Council on Aging (NCOA)
How (HIMS) Movements Inform Risk Allocation Models - Stock Traders Daily
What are the hidden costs of weight loss for Americans? - leader-call.com
Healthcare Stocks To ConsiderJanuary 22nd - MarketBeat
HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? - Yahoo Finance
Why Hims & Hers Stock Slipped Today - AOL.com
QRG Capital Management Inc. Decreases Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Emerald Advisers LLC Acquires New Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock By Investing.com - Investing.com South Africa
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock - Investing.com
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 9,067 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Stock Price Down 6.2%Here's Why - MarketBeat
Hims & Hers Health Inc. Stock (HIMS) Opinions on Recent Price Decline - Quiver Quantitative
Best Healthcare Stocks To ConsiderJanuary 5th - MarketBeat
Hims & Hers Health (NYSE:HIMS) Downgraded to "Strong Sell" Rating by Zacks Research - MarketBeat
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Hims & Hers Health Stock Outlook: Modeling a 95% Upside Case - TIKR.com
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets - MSN
Hims And Hers Wegovy Talks Could Reshape Growth And Subscriber Economics - simplywall.st
2 Top Stocks to Double Up On Right Now - Yahoo Finance
Why Hims & Hers Health (HIMS) Stock Is Down Today - Finviz
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Hims & Hers Expands Platform-Led Access to Digital Healthcare - The Globe and Mail
Published on: 2026-01-18 05:20:30 - baoquankhu1.vn
Portfolio Recap: Does SKLZ stock benefit from AI growthJuly 2025 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Market Review: Is Hims Hers Health Inc a top pick in the sectorMarket Risk Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hims GLP-1 Weight Loss Guide 2026: Injectable and Oral Treatment Options for Men (Semaglutide and Tirzepatide) - Newswire.com
Hims & Hers And HIMZ: Short‑Term Pain From Novo, Long‑Term Opportunity Still Bright (HIMS) - Seeking Alpha
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Hims & Hers Shares Face Heightened Volatility on Key Expiry Date - AD HOC NEWS
Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s - Sherwood News
Is Hims & Hers (HIMS) Using Zava to Balance GLP-1 Uncertainty with Broader Platform Ambitions? - Sahm
Promising Healthcare Stocks To Follow NowJanuary 14th - MarketBeat
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers: Growth Catalysts Or Margin Trap (NYSE:HIMS) - Seeking Alpha
2.84%
0.58%
자본화:
|
볼륨(24시간):